TP53 alteration (mutation or deletion), PTEN, and CDKN2A deletion occurred together in seven samples, 6/46 (13%) astrocytomas, and 1/4 (25%) oligodendrogliomas. This evidence concerns the gene PTEN and astrocytoma (excluding glioblastoma).